Institutional Ownership Summit Therapeutics Inc. (SMMT)
This table provides information about the institutional ownership of Summit Therapeutics Inc. (SMMT). We have compiled data on the 246 institutions that hold shares in the stock, with a total of 87.4 Million shares, which have been reported (via 13F filing form) to have a value of $2.62 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Baker Bros. Advisors LP
New York, NY |
May 15, 2025 Q1 2025 |
24,424,865
shares
|
$733 Million
5.62% of portfolio
|
Q3 2024
Added 5.18%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
11,640,507
shares
|
$349 Million
0.0% of portfolio
|
Q1 2025
Reduced 0.26%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
7,898,585
shares
|
$237 Million
0.0% of portfolio
|
Q2 2024
Reduced 19.59%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
6,557,804
shares
|
$197 Million
0.02% of portfolio
|
Q1 2025
Reduced -0.0%
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
4,851,388
shares
|
$146 Million
0.0% of portfolio
|
Q1 2025
Reduced 13.41%
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
3,284,882
shares
|
$98.6 Million
0.01% of portfolio
|
Q1 2025
Added 2.63%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
May 05, 2025 Q1 2025 |
2,661,604
shares
|
$79.9 Million
0.06% of portfolio
|
Q1 2025
Added 91.86%
|
|
Balyasny Asset Management LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
1,703,180
shares
|
$51.1 Million
0.06% of portfolio
|
Q1 2025
Added 339.82%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
1,460,717
shares
|
$43.9 Million
0.01% of portfolio
|
Q1 2025
Reduced 1.64%
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
1,264,223
shares
|
$38 Million
0.0% of portfolio
|
Q1 2025
Added 6.56%
|
|
Apeiron Capital LTD
|
Jul 25, 2025 Q2 2025 |
1,200,941
shares
|
$36.1 Million
22.1% of portfolio
|
Q2 2025
New holding
|
|
Abrdn PLC
|
Jul 24, 2025 Q2 2025 |
1,139,530
shares
|
$34.2 Million
0.04% of portfolio
|
Q2 2025
Reduced 5.1%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
998,740
shares
|
$30 Million
0.0% of portfolio
|
Q1 2025
Added 432.93%
|
|
Rock Springs Capital Management LP
Baltimore, MD |
May 15, 2025 Q1 2025 |
995,000
shares
|
$29.9 Million
1.15% of portfolio
|
Q1 2025
Reduced 5.6%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
887,009
shares
|
$26.6 Million
0.01% of portfolio
|
Q1 2025
Reduced 56.73%
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
843,650
shares
|
$25.3 Million
0.0% of portfolio
|
Q1 2025
Reduced 3.18%
|
|
Candriam S.C.A.
|
May 14, 2025 Q1 2025 |
838,518
shares
|
$25.2 Million
0.1% of portfolio
|
Q1 2025
Reduced 0.48%
|
|
Siren, L.L.C.
New York, NY |
May 14, 2025 Q1 2025 |
695,000
shares
|
$20.9 Million
0.76% of portfolio
|
Q1 2025
New holding
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
575,619
shares
|
$17.3 Million
0.0% of portfolio
|
Q1 2025
Added 312.39%
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
572,791
shares
|
$17.2 Million
0.0% of portfolio
|
Q1 2025
Reduced 6.39%
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
May 15, 2025 Q1 2025 |
538,000
shares
|
$16.2 Million
0.02% of portfolio
|
Q1 2025
New holding
|
|
Td Asset Management Inc
|
Jul 28, 2025 Q2 2025 |
484,010
shares
|
$14.5 Million
0.01% of portfolio
|
Q2 2025
Reduced 40.04%
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
478,126
shares
|
$14.4 Million
0.0% of portfolio
|
Q1 2025
Reduced 14.77%
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
May 15, 2025 Q1 2025 |
466,164
shares
|
$14 Million
0.01% of portfolio
|
Q1 2025
Reduced 2.23%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
May 09, 2025 Q1 2025 |
427,619
shares
|
$12.8 Million
0.0% of portfolio
|
Q4 2024
Added 11.97%
|